A modification of rat adjuvant arthritis for testing antirheumatic drugs.
D000276:Adjuvants, Immunologic; D000632:Aminopyrine / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001168:Arthritis / Q000276:immunology; D001241:Aspirin / Q000627:therapeutic use; D002351:Carrageenan; D002738:Chloroquine / Q000494:pharmacology / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004195:Disease Models, Animal; D005260:Female; D005439:Flufenamic Acid / Q000627:therapeutic use; D006046:Gold / Q000494:pharmacology; D006854:Hydrocortisone / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D007249:Inflammation / Q000139:chemically induced*; D010653:Phenylbutazone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D051381:Rats; D013870:Thiomalates / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D013870:Thiomalates; D000632:Aminopyrine; D005439:Flufenamic Acid; D006046:Gold; D003907:Dexamethasone; D002738:Chloroquine; D002351:Carrageenan; D011239:Prednisolone; D010653:Phenylbutazone; D001241:Aspirin; D006854:Hydrocortisone; D007213:Indomethacin